LD-2 disclosure · 1st Quarter - Amendment
STUDENTS FOR SENSIBLE DRUG POLICY
Coverage · No income or expenses were reported on this filing.
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Drug policy reform advocacy
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesCivil Rights/Civil Liberties
Cannabis legalization and retroactive justice Psychedelic therapy & research Ending the War on Drugs
LobbyistsKAT MURTI
Covered position (KAT MURTI): Executive Director
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Justice, Dept of (DOJ) · Drug Enforcement Administration (DEA)
Alcohol and Drug Abuse
Ending the War on Drugs Controlled Substance Act Scheduling
LobbyistsKAT MURTI
Covered position (KAT MURTI): Executive Director
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Justice, Dept of (DOJ) · Drug Enforcement Administration (DEA)
Medical/Disease Research/Clinical Labs
Preventing unscheduled research chemicals DOI and DOC from being added to Schedule I of the CSA
LobbyistsKAT MURTI
Executive Director